The University of Chicago Header Logo

Connection

Olufunmilayo Olopade to Contraceptives, Oral

Back to Details
This is a "connection" page, showing publications Olufunmilayo Olopade has written about Contraceptives, Oral.
Olufunmilayo Olopade
Connection Strength
0.093
Contraceptives, Oral
  1. Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives. Pharmacogenetics. 2001 Oct; 11(7):635-8.
    View in: PubMed
    Score: 0.048
  2. Breastfeeding and the risk of epithelial ovarian cancer among women with a BRCA1 or BRCA2 mutation. Gynecol Oncol. 2020 12; 159(3):820-826.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.